Permeability and residual plasma volume of human, Dutch variant, and rat amyloid beta-protein 1-40 at the blood-brain barrier
- PMID: 9258909
- DOI: 10.1006/nbdi.1997.0132
Permeability and residual plasma volume of human, Dutch variant, and rat amyloid beta-protein 1-40 at the blood-brain barrier
Abstract
The permeability of normal human, the human Dutch variant, and the rat A beta 1-40 proteins at the blood-brain barrier (BBB) was determined in the normal adult rat by quantifying the permeability coefficient-surface area (PS) product for each protein after correction for the residual plasma volume (Vp) occupied by the protein in the blood vessels of different brain regions. The PS for normal and Dutch A beta ranged from 13 x 10(-6) to 22 x 10(-6) ml/g/s in different brain regions, which is 130 to 220 times greater than albumin. These high PS values compare to that of insulin, whose uptake is decidedly by a receptor-mediated transport process, and suggest a similar mechanism for A beta. Remarkably, the PS for rat A beta was 4 times higher and ranged from 54 x 10(-6) to 82 x 10(-6) ml/g/s for different brain regions, suggesting a distinctive species specificity. While the Vp values of human and rat A beta were comparable, the Dutch variant was 2 to 3 times higher, indicating adherence to the vessel walls in different brain regions, consistent with the heavy A beta deposition that has been described in intracerebral vessel walls with this variant. The high PS values observed for A beta at the BBB suggest that sources outside the nervous system could contribute, at least in part, to the cerebral A beta deposits seen in Alzheimer's disease. SDS-PAGE of 125I-labeled human A beta after 60 min of uptake revealed intact protein in plasma and in different brain regions. In addition, 125I-labeled human A beta binding to a protein of 67,000 in both plasma and brain tissue regions was observed with SDS-PAGE. This protein was tentatively identified as albumin, and it was not detectable in the brain regions of animals that had undergone intracardiac perfusion; hence, a portion of A beta binds tightly to and is likely transported by albumin in plasma. The absence of this A beta-albumin complex in brain regions after perfusion and the low permeability of albumin at the BBB imply that A beta itself is efficiently transported at the BBB to account for the high PS values, although presentation of A beta to the capillary endothelial cell by albumin or other plasma proteins cannot be excluded.
Comment in
-
Can blood-brain barrier play a role in the development of cerebral amyloidosis and Alzheimer's disease pathology.Neurobiol Dis. 1997;4(1):23-6. doi: 10.1006/nbdi.1997.0134. Neurobiol Dis. 1997. PMID: 9258908 Review. No abstract available.
Similar articles
-
Receptor-mediated transport of human amyloid beta-protein 1-40 and 1-42 at the blood-brain barrier.Neurobiol Dis. 1999 Jun;6(3):190-9. doi: 10.1006/nbdi.1999.0238. Neurobiol Dis. 1999. PMID: 10408808
-
Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.Neurobiol Dis. 2001 Aug;8(4):555-67. doi: 10.1006/nbdi.2001.0402. Neurobiol Dis. 2001. PMID: 11493021
-
Beta-sheet breaker peptide inhibitor of Alzheimer's amyloidogenesis with increased blood-brain barrier permeability and resistance to proteolytic degradation in plasma.J Neurobiol. 1999 Jun 5;39(3):371-82. J Neurobiol. 1999. PMID: 10363910
-
Brain iron homeostasis.Dan Med Bull. 2002 Nov;49(4):279-301. Dan Med Bull. 2002. PMID: 12553165 Review.
-
Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.J Neuropathol Exp Neurol. 2008 Apr;67(4):261-70. doi: 10.1097/NEN.0b013e31816a0dc8. J Neuropathol Exp Neurol. 2008. PMID: 18379441 Review.
Cited by
-
Links between the pathology of Alzheimer's disease and vascular dementia.Neurochem Res. 2004 Jun;29(6):1257-66. doi: 10.1023/b:nere.0000023612.66691.e6. Neurochem Res. 2004. PMID: 15176482
-
Insulin Signaling Differentially Regulates the Trafficking of Insulin and Amyloid Beta Peptides at the Blood-Brain Barrier.Mol Pharm. 2024 May 6;21(5):2176-2186. doi: 10.1021/acs.molpharmaceut.3c00784. Epub 2024 Apr 16. Mol Pharm. 2024. PMID: 38625027 Free PMC article.
-
Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.J Cereb Blood Flow Metab. 2007 May;27(5):909-18. doi: 10.1038/sj.jcbfm.9600419. Epub 2006 Nov 1. J Cereb Blood Flow Metab. 2007. PMID: 17077814 Free PMC article.
-
The dynamics of Aβ distribution after γ-secretase inhibitor treatment, as determined by experimental and modelling approaches in a wild type rat.J Pharmacokinet Pharmacodyn. 2012 Jun;39(3):227-37. doi: 10.1007/s10928-012-9246-4. Epub 2012 Apr 6. J Pharmacokinet Pharmacodyn. 2012. PMID: 22481485
-
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.Nat Rev Neurosci. 2011 Nov 3;12(12):723-38. doi: 10.1038/nrn3114. Nat Rev Neurosci. 2011. PMID: 22048062 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials